[go: up one dir, main page]

WO2002045687A3 - Topical alcoholic solution of a salicylic acid derivative and acemannan - Google Patents

Topical alcoholic solution of a salicylic acid derivative and acemannan Download PDF

Info

Publication number
WO2002045687A3
WO2002045687A3 PCT/GB2001/005380 GB0105380W WO0245687A3 WO 2002045687 A3 WO2002045687 A3 WO 2002045687A3 GB 0105380 W GB0105380 W GB 0105380W WO 0245687 A3 WO0245687 A3 WO 0245687A3
Authority
WO
WIPO (PCT)
Prior art keywords
acemannan
acid derivative
salicylic acid
alcoholic solution
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/005380
Other languages
French (fr)
Other versions
WO2002045687A2 (en
Inventor
Henrik Steenfeldt-Foss
Per Stanley Thrane
Jo Klaveness
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORWAY MEDICAL GROUP INT AS
Original Assignee
NORWAY MEDICAL GROUP INT AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORWAY MEDICAL GROUP INT AS filed Critical NORWAY MEDICAL GROUP INT AS
Priority to EP01999356A priority Critical patent/EP1349540A2/en
Priority to AU2002218419A priority patent/AU2002218419A1/en
Publication of WO2002045687A2 publication Critical patent/WO2002045687A2/en
Publication of WO2002045687A3 publication Critical patent/WO2002045687A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention provides an alcoholic solution of a physiologically tolerable salicylic acid derivative and an acemannan for use in topical treatment of herpetic neuralgia. The invention also provides a method of treatment of herpetic neuralgia in a human subject which comprises applying an analgesically effective amount of such a solution to the affected area.
PCT/GB2001/005380 2000-12-05 2001-12-05 Topical alcoholic solution of a salicylic acid derivative and acemannan Ceased WO2002045687A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01999356A EP1349540A2 (en) 2000-12-05 2001-12-05 Topical alcoholic solution of a salicylic acid derivative and acemannan
AU2002218419A AU2002218419A1 (en) 2000-12-05 2001-12-05 Topical alcoholic solution of a salicylic acid derivative and acemannan

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0029634.3 2000-12-05
GBGB0029634.3A GB0029634D0 (en) 2000-12-05 2000-12-05 Use

Publications (2)

Publication Number Publication Date
WO2002045687A2 WO2002045687A2 (en) 2002-06-13
WO2002045687A3 true WO2002045687A3 (en) 2003-04-10

Family

ID=9904475

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/005380 Ceased WO2002045687A2 (en) 2000-12-05 2001-12-05 Topical alcoholic solution of a salicylic acid derivative and acemannan

Country Status (4)

Country Link
EP (1) EP1349540A2 (en)
AU (1) AU2002218419A1 (en)
GB (1) GB0029634D0 (en)
WO (1) WO2002045687A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534235B1 (en) * 2002-06-25 2016-07-27 Acrux DDS Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
CA2555366A1 (en) * 2004-02-16 2005-08-25 Teikoku Seiyaku Co., Ltd. Remedy for external use for skin and mucosal injuries caused by viral infection
FR3130556A1 (en) * 2021-12-16 2023-06-23 L'oreal Use of salicylic acid and/or its derivatives and/or their salts, for increasing or restoring cutaneous tactile perception
WO2025114578A1 (en) 2023-11-29 2025-06-05 Auxesis Pharma Holding Ab (Publ) A composition and use thereof as a medicament

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
US4942031A (en) * 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
EP0405299A2 (en) * 1989-06-23 1991-01-02 Giuseppe De Benedittis Composition for the treatment of acute herpetic neuralgia and post-herpetic neuralgia
US5034221A (en) * 1989-06-22 1991-07-23 Rosen Steven E Topical agent and method for the treatment of Pseudofolliculitis barbae
WO1993021899A1 (en) * 1992-05-05 1993-11-11 The Procter & Gamble Company Acne treating composition
US5736126A (en) * 1996-03-15 1998-04-07 Van Engelen; H. Wayne Liquid transdermal analgesic
WO2000078354A1 (en) * 1999-06-22 2000-12-28 Norway Medical Group Int As Topical composition comprising acetyl salicylic acid

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
US4942031A (en) * 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
US5034221A (en) * 1989-06-22 1991-07-23 Rosen Steven E Topical agent and method for the treatment of Pseudofolliculitis barbae
EP0405299A2 (en) * 1989-06-23 1991-01-02 Giuseppe De Benedittis Composition for the treatment of acute herpetic neuralgia and post-herpetic neuralgia
WO1993021899A1 (en) * 1992-05-05 1993-11-11 The Procter & Gamble Company Acne treating composition
US5736126A (en) * 1996-03-15 1998-04-07 Van Engelen; H. Wayne Liquid transdermal analgesic
WO2000078354A1 (en) * 1999-06-22 2000-12-28 Norway Medical Group Int As Topical composition comprising acetyl salicylic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SWERDLOW M: "TOPICAL APPLICATIONS FOR PAIN THERAPY IN POST-HERPETIC NEURALGIA", PAIN CLINIC, VNU, UTRECHT, NL, vol. 6, no. 3, 1993, pages 153 - 156, XP001057955, ISSN: 0169-1112 *

Also Published As

Publication number Publication date
GB0029634D0 (en) 2001-01-17
EP1349540A2 (en) 2003-10-08
AU2002218419A1 (en) 2002-06-18
WO2002045687A2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
AU1449401A (en) Method using prior activities to improve the completion of transaction
AU2210400A (en) Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
AU2002338343A1 (en) Method and system for using cooperative game theory to resolve statistical joint effects
MXPA03006727A (en) Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications.
PL362477A1 (en) Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
AU2002319739A1 (en) System and method for the interactive trading of derivatives
AU2002362482A1 (en) Acne treatment using oleanolic acid
BR0009158B1 (en) ascorbic acid based topical composition for the treatment of skin damage
AU2001288956A1 (en) System and method for an online jurisdiction manager
AU2003265010A1 (en) Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
AU2002241956A1 (en) Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
WO1999045920A3 (en) The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
WO2004084943A8 (en) Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
WO1998018440A3 (en) Use of inhibitors of the activity of retinoic acid for treating sensitive skin
ID29792A (en) CONTROLLED REMOVAL FORMULATION TO TREAT CORP
WO2007022509A3 (en) Use of seh inhibitors as analgesics
AU2001290961A1 (en) Method for topical treatment of anthralin-responsive dermatological disorders
WO2002045687A3 (en) Topical alcoholic solution of a salicylic acid derivative and acemannan
AU2001232390A1 (en) The method of the game for one to many persons on the online
ITRM990707A0 (en) COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF DISORDERS DUE TO ALTERED METABOLISM OF LIPIDS, WHICH INCLUDES PROPIONIL L-MEATS
AU5327800A (en) Methods for treating skin with 3-hydroxy benzoic acid and related compositions
WO2005070370A8 (en) Method and preparation for reducing sunburn cell formation in skin
AU2003277132A1 (en) Method and system for secure person to person payment
AU2001255487A1 (en) Salicylic acid acne spray formulations and methods for treating acne with same
AU2003273247A1 (en) Non-invasive methods to identify agents for treating pain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001999356

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002218419

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2001999356

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001999356

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP